Missed it deep in the Application for Quotation notice.
As announced in the Appendix 3B released on 26 October 2023, 2,000,000 shares are proposed to be issued. The first tranche of 1,539,150 shares were issued on 2 November 2023. The second tranche was revised to 125,000 shares and it is now planned that the remaining 335,850 shares will be issued on or before 15 December 2023 with the intention to close as soon as possible.
- Forums
- ASX - By Stock
- AVR
- Ann: 30-day Haemodynamic Results from the DurAVR US EFS Trial
AVR
anteris technologies global corp.
Add to My Watchlist
3.43%
!
$5.91

Ann: 30-day Haemodynamic Results from the DurAVR US EFS Trial, page-57
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$5.91 |
Change
-0.210(3.43%) |
Mkt cap ! $91.59M |
Open | High | Low | Value | Volume |
$6.01 | $6.08 | $5.85 | $44.71K | 7.43K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 857 | $5.83 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.08 | 260 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 857 | 5.830 |
1 | 900 | 5.780 |
1 | 1000 | 5.610 |
2 | 3500 | 5.600 |
2 | 3736 | 5.500 |
Price($) | Vol. | No. |
---|---|---|
6.080 | 260 | 1 |
6.180 | 50 | 1 |
6.200 | 1000 | 1 |
6.400 | 130 | 1 |
6.500 | 255 | 1 |
Last trade - 15.51pm 26/06/2025 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online